Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 115697
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.115697
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.115697
Figure 6 Effects of icaritin on colon cancer formation in vivo.
Thirty-nine days after establishment of the xenograft model, all mice were sacrificed and subcutaneous tumors were dissected. A: Volume and weight of dissected tumors; B: Positive cells, characterized by brown granules in the nuclei, were identified in the immunohistochemistry assay assessing Ki67. Indexes are shown as mean ± SD (n = 5), P < 0.05 compared with the control group.
- Citation: Li X, Li YJ, Ren DD, Yuan M, Qi YR, Li HW, Zhang Y, Wang RY. Icaritin suppresses colorectal cancer invasion and metastasis through regulation of epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway. World J Gastrointest Oncol 2026; 18(5): 115697
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/115697.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.115697